27 results
DEFR14A
ARCT
Arcturus Therapeutics Holdings Inc
12 May 22
Revised proxy
5:00pm
to the public health impact of the coronavirus outbreak and to support the health and well-being of our employees, stockholders, and our community, the Annual
8-K
EX-14.1
41o 4txnczqo
13 Dec 21
Arcturus Therapeutics Appoints Jing Marantz, M.D., Ph.D., M.B.A. to its Board of Directors
5:17pm
424B5
diqnjau7hjqq
8 Dec 20
Prospectus supplement for primary offering
5:30pm
424B5
b0wsrc
7 Dec 20
Prospectus supplement for primary offering
5:20pm
PRE 14A
mzs2 8sl4dytvyfaeel
2 Oct 20
Preliminary proxy
4:20pm
S-8
EX-4.3
hd3vkd98i
5 Aug 20
Registration of securities for employees
12:00am
424B5
d0weg
30 Jul 20
Prospectus supplement for primary offering
6:01am
424B5
omyua y2vzpntgen9s
28 Jul 20
Prospectus supplement for primary offering
4:17pm